Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study (original) (raw)

Abstract

Preoperative selective internal radiation therapy (SIRT) may improve the results of partial hepatectomy (PH) or radiofrequency destruction (RF) for hepatocellular carcinoma (HCC) in patients with cirrhosis. The aim of this study was to evaluate the feasibility and safety of this combined approach. Patients with cirrhosis and HCC selected for PH or RF were prospectively included and systematically proposed for preoperative SIRT. Feasibility and safety of SIRT and post-SIRT PH or RF were assessed. Thirty patients were included. SIRT was contraindicated in seven, due to lack of access to tumour artery or to hepato-pulmonary shunts. SIRT was performed in 23 patients without significant complications. Post-SIRT, surgery was refuted in seven patients, due to tumour progression or the patient's deteriorating condition. After surgery, major complications were observed in 2/16 patients (12.5%) and one patient died 52 days post-surgery. A major tumour pathological response was seen in mos...

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (38)

  1. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908-943.
  2. Forner A, Gilabert M, Bruix J, Raoul JL. (2014) Treatment of intermediate-stage hepatocellular carcinoma. Nat Rev Clin Oncol 11: 525-535. HPB 2018, 20, 641-648 © 2018 Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.
  3. Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY et al. (2009) A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 249:195-202.
  4. Kaibori M, Tanigawa N, Kariya S, Ikeda H, Nakahashi Y, Hirohara J et al. (2012) A prospective randomized controlled trial of preoperative whole- liver chemolipiodolization for hepatocellular carcinoma. Dig Dis Sci 57: 1404-1412.
  5. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, P'Eng FK. (1995) Preoperative transcatheter arterial chemoembolization for resectable large hepato- cellular carcinoma: a reappraisal. Br J Surg 82:122-126.
  6. Cabibbo G, Latteri F, Antonucci M, Craxi A. (2009) Multimodal ap- proaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol 6:159-169.
  7. Si T, Chen Y, Ma D, Gong X, Yang K, Guan R et al. (2016) Preoperative transarterial chemoembolization for resectable hepatocellular carci- noma in Asia area: a meta-analysis of random controlled trials. Scand J Gastroenterol 51:1512-1519.
  8. Bruix J, Takayama T, Mazzaferro V, Chau GY, Yang J, Kudo M et al. (2015) Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo- controlled trial. Lancet Oncol 16:1344-1354.
  9. Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF et al. (2006) Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94:572-586.
  10. Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y et al. (2010) Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting. J Clin Oncol 28: 3994-4005.
  11. Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, Morosi C et al. (2013) Yttrium-90 radioembolization for intermediate-advanced hepa- tocellular carcinoma: a phase 2 study. Hepatology 57:1826-1837.
  12. Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK et al. (2011) Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocel- lular carcinoma. Gastroenterology 140:497-507. e492.
  13. Salem R, Gordon AC, Mouli S, Hickey R, Kallini J, Gabr A et al. (2016) Y90 Radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular car- cinoma. Gastroenterology 151:1155-1163.
  14. Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S et al. (2011) Survival after yttrium-90 resin microsphere radio- embolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology 54:868-878.
  15. Whitney R, Tatum C, Hahl M, Ellis S, Scoggins CR, McMasters K et al. (2011) Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J Surg Res 166:236-240.
  16. Brown RE, Bower MR, Metzger TL, Scoggins CR, McMasters KM, Hahl MJ et al. (2011) Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? HPB (Oxford) 13:91-95.
  17. Inarrairaegui M, Pardo F, Bilbao JI, Rotellar F, Benito A, D'Avola D et al. (2012) Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol 38: 594-601.
  18. Justinger C, Kouladouros K, Gartner D, Tatsch K, Reimer P, Rudiger T et al. (2015) Liver resection after selective internal radiotherapy (SIRT): proof of concept, initial survival, and safety. J Surg Oncol 112: 436-442.
  19. Bouazza F, Poncelet A, Garcia CA, Delatte P, Engelhom JL, Gomez Galdon M et al. (2015) Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma. World J Gastro- enterol 21:9666-9670.
  20. Pardo F, Sangro B, Lee RC, Manas D, Jeyarajah R, Donckier V et al. (2017) The Post-SIR-Spheres Surgery Study (P4S): retrospective anal- ysis of safety following hepatic resection or transplantation in patients previously treated with selective internal radiation therapy (SIRT) with yttrium-90 resin microspheres. Ann Surg Oncol in press.
  21. Van den Eynde M, Flamen P, El Nakadi I, Liberale G, Delatte P, Larsimont D et al. (2008) Inducing resectability of chemotherapy re- fractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres. Clin Nucl Med 33:697-699.
  22. Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK et al. (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radio- embolization. Am J Transplant 9:1920-1928.
  23. Gaba RC, Lewandowski RJ, Kulik LM, Riaz A, Ibrahim SM, Mulcahy MF et al. (2009) Radiation lobectomy: preliminary findings of hepatic volu- metric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 16:1587-1596.
  24. Gulec SA, Pennington K, Hall M, Fong Y. (2009) Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections. World J Surg Oncol 7:6.
  25. Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK et al. (2013) Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol 59:1029-1036.
  26. Edeline J, Lenoir L, Boudjema K, Rolland Y, Boulic A, Le Du F et al. (2013) Volumetric changes after (90)y radioembolization for hepatocel- lular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Ann Surg Oncol 20:2518-2525.
  27. Lewandowski RJ, Donahue L, Chokechanachaisakul A, Kulik L, Mouli S, Caicedo J et al. (2016) (90) Y radiation lobectomy: outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes. J Surg Oncol 114:99-105.
  28. Dindo D, Demartines N, Clavien PA. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 pa- tients and results of a survey. Ann Surg 240:205-213.
  29. Hu RH, Lee PH, Yu SC, Dai HC, Sheu JC, Lai MY et al. (1996) Surgical resection for recurrent hepatocellular carcinoma: prognosis and anal- ysis of risk factors. Surgery 120:23-29.
  30. Minagawa M, Makuuchi M, Takayama T, Kokudo N. (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238:703-710.
  31. Roayaie S, Bassi D, Tarchi P, Labow D, Schwartz M. (2011) Second hepatic resection for recurrent hepatocellular cancer: a Western expe- rience. J Hepatol 55:346-350.
  32. Kluger MD, Salceda JA, Laurent A, Tayar C, Duvoux C, Decaens T et al. (2015) Liver resection for hepatocellular carcinoma in 313 Western pa- tients: tumor biology and underlying liver rather than tumor size drive prognosis. J Hepatol 62:1131-1140.
  33. HPB 2018, 20, 641-648 © 2018 Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc. HPB 33. Vincenzi B, Di Maio M, Silletta M, D'Onofrio L, Spoto C, Piccirillo MC et al. (2015) Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: a literature-based meta-analysis. PLoS One 10:e0133488.
  34. Asman Y, Evenson AR, Even-Sapir E, Shibolet O. (2015) [18F]fludeox- yglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco- ablative therapies for hepatocellular carcinoma. Liver Transpl 21: 572-580.
  35. Lee JW, Oh JK, Chung YA, Na SJ, Hyun SH, Hong IK et al. (2016) Prognostic significance of (1)(8)F-FDG uptake in hepatocellular carci- noma treated with transarterial chemoembolization or concurrent chemoradiotherapy: a multicenter retrospective cohort study. J Nucl Med 57:509-516.
  36. Ishii M, Mizuguchi T, Harada K, Ota S, Meguro M, Ueki T et al. (2014) Comprehensive review of post-liver resection surgical complications and a new universal classification and grading system. World J Hepatol 6:745-751.
  37. Twaij A, Pucher PH, Sodergren MH, Gall T, Darzi A, Jiao LR. (2014) Laparoscopic vs open approach to resection of hepatocellular carci- noma in patients with known cirrhosis: systematic review and meta- analysis. World J Gastroenterol 20:8274-8281.
  38. Lim KC, Chow PK, Allen JC, Siddiqui FJ, Chan ES, Tan SB. (2012) Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg 99:1622-1629.